Markets

Cara Therapeutics (CARA) Jumps: Stock Moves Up 16.6%

Cara Therapeutics Inc. ( CARA ) was a big mover last session, as its shares rose roughly 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday's rally breaks the downtrend for the company since Sep 18, as the stock is now down over 34%.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cara Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably ranked biomedical stock is Anika Therapeutics Inc. ( ANIK ) with a Zacks Rank #1 (Strong Buy).

Is CARA going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CARA THERAPEUTC (CARA): Free Stock Analysis Report

ANIKA THERAPEUT (ANIK): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ANIK CARA

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More